Search
for
Sort by
Research 391–420 of 1000+
- Effectiveness and safety of Baricitinib in alopecia areata: a prospective cohort study
- Alterations in Corneal Sensitivity, Staining and Biomechanics of Alopecia Areata Patients: Novel Findings in a Case-Control Study
- Improvement in health‐related quality of life and symptoms of anxiety and depression in patients with alopecia areata randomized to baricitinib or placebo: Results from two international randomized controlled trials
- Clinical and demographic characteristics associated with nail involvement in alopecia areata: A cross‐sectional study of 197 patients
- The Role of Tofacitinib in the Management of Alopecia Totalis
- Erosive pustular dermatosis of the scalp: a multicentre study
- Approach to androgen excess in women: Clinical and biochemical insights
- A Case of Unexpected Successful Treatment of Alopecia Areata With Tralokinumab in a Patient With Atopic Dermatitis
- Trichoscopic findings in various alopecias at tertiary referral center: A cross-sectional study
- Morphological, molecular and histopathological identification of Sarcoptes scabieiinfection in a goat herd at Goa, India
- Effectiveness of Baricitinib on Nail Alopecia Areata: A 48-Week Single-Center Retrospective Study
- JAK Inhibitor Therapy in Alopecia Areata with Latent Hepatitis B Virus or Tuberculosis Infection: A Safety Assessment
- 6ER-014 Evaluation of baricitinib in paediatric patients with alopecia areata
- Using patient preference to inform ritlecitinib dose selection for alopecia areata treatment
- Alopecia universalis with IL-12-RB1 and STAT4 mutations effectively treated with upadacitinib
- Erythroderma, Alopecia, Anhidrosis, and Vitiligo as Complications of a Red Ink Tattoo—A Case Report
- Trichoscopy in the Diagnosis of Alopecia Areata
- Assessment, reliability, and validity of trichoscopy in the evaluation of alopecia in women
- Comprehensive Evaluation of Androgenetic Alopecia: Demographic Characteristics, Psychosocial Impact, and the Role of Social Media in Treatment Choices
- Letter from the editor: Making sense of central centrifugal cicatricial alopecia
- Efficacy and safety of deuruxolitinib, an oral selective Janus kinase 1/2 inhibitor, in adults with alopecia areata: Results from the THRIVE-AA2 Phase 3, randomized, double-blind, controlled trial
- Population exposure–response analysis of the effect of ritlecitinib on eyebrow assessment and eyelash assessment in patients with alopecia areata
- Effectiveness of Abrocitinib in Adolescent Alopecia Areata: A Prospective Observational Pilot Study
- Baricitinib Achieved Complete/Near Complete Scalp Coverage in SALT Score ≤20 Responders: 52-Week Findings From BRAVE-AA Trials
- Treatment of alopecia areata with JAK inhibitors: a review of the literature
- Adipose Tissue–Derived Exosomes as a Novel Therapeutic Approach for Refractory Alopecia Areata: A Report of Two Cases
- Race and Ethnicity Sub-Groups of Alopecia Areata Patients have Differing Clinical Characteristics: TARGET-DERM AA
- Quality of life assessment in males with androgenetic alopecia – a prospective study
- Systematic investigation of a potential epidemiological and genetic association between male androgenetic alopecia and COVID‐19
- Selenoproteins Are Essential for Proper Keratinocyte Function and Skin Development